Showing results (211-220 of 231) with videos related to

Sort By:
Pageof 24
Medical and Pediatric Oncology|January 1, 1980
A new therapy schedule for pediatric non-Hodgkin lymphoma toxicity with preliminary resultsA T Meadows, R D Jenkin, J Anderson, et al.
Journal of Inherited Metabolic Disease|July 18, 2002
Vitamin C therapy ameliorates vascular endothelial dysfunction in treated patients with homocystinuriaC H Pullin, J R Bonham, I F W McDowell, et al.
American Journal of Human Genetics|February 15, 2001
A predominantly indigenous paternal heritage for the Austronesian-speaking peoples of insular Southeast Asia and OceaniaC Capelli, J F Wilson, M Richards, et al.
Forensic Science International|August 23, 2001
External quality assessment of laboratory performance in analysis of toxicological casesJ F Wilson, P A Toseland, N E Capps, et al.
Therapeutic Drug Monitoring|June 19, 1998
An audit of therapeutic drug monitoring service provision by laboratories participating in an external quality assessment schemeA H Thomson, I D Watson, J F Wilson, et al.
Human Pathology|October 1, 1987
The pathology of non-Hodgkin's lymphoma of childhood: II. Reproducibility and relevance of the histologic classification of "undifferentiated" lymphomas (Burkitt's versus non-Burkitt's)J F Wilson, C R Kjeldsberg, R Sposto, et al.
Radiology|October 1, 1992
Periocular lymphoproliferative diseases: natural history, prognostic factors, and treatmentB A Erickson, G J Harris, C A Enke, et al.
Cancer|April 15, 1984
Studies on the pathology of non-Hodgkin's lymphoma of childhood. I. The role of routine histopathology as a prognostic factor. A report from the Children's Cancer Study GroupJ F Wilson, R D Jenkin, J R Anderson, et al.
The Cancer Journal From Scientific American|January 1, 1997
Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survivalA D Morris, R D Morris, J F Wilson, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 1, 1996
Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancerR W Byhardt, L Vaickus, P L Witt, et al.
Pageof 24